Author

Lisa M. Reeves

Observed names: L. M. REEVES, LISA M. REEVES, Lisa M Reeves, Lisa Reeves

Institution: Pfizer (United States)

Observed institution: Pfizer (United States)

OpenAlex ID: A5087830424

Synthesis and biological activity of selective pipecolic acid-based TNF-α converting enzyme (TACE) inhibitors

2002 · Michael A. Letavic, Matt Z. Axt, et al. · Bioorganic & Medicinal Chemistry Letters · 75

Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13

2005 · Mark C. Noe, Vijayalakshmi Natarajan, et al. · Bioorganic & Medicinal Chemistry Letters · 44

Synthesis and biological activity of piperazine-Based dual MMP-13 and TNF-α converting enzyme inhibitors

2003 · Michael A. Letavic, John T. Barberia, et al. · Bioorganic & Medicinal Chemistry Letters · 40

Discovery of 3-OH-3-methylpipecolic hydroxamates: Potent orally active inhibitors of aggrecanase and MMP-13

2005 · Mark C. Noe, Vijayalakshmi Natarajan, et al. · Bioorganic & Medicinal Chemistry Letters · 37

Structure-Based Design and Synthesis of a Potent Matrix Metalloproteinase-13 Inhibitor Based on a Pyrrolidinone Scaffold

2000 · Ralph P. Robinson, Ellen R. Laird, et al. · Journal of Medicinal Chemistry · 36

Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket

1999 · Lawrence A. Reiter, James P. Rizzi, et al. · Bioorganic & Medicinal Chemistry Letters · 36

3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase

2004 · Mark C. Noe, Sheri L. Snow, et al. · Bioorganic & Medicinal Chemistry Letters · 22

Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors

2001 · Ralph P Robinson, Ellen R Laird, et al. · Bioorganic & Medicinal Chemistry Letters · 21

MMP‐13 and MMP‐1 Expression in Tissues of Normal Articular Joints

1999 · SUE A. YOCUM, LORI L. LOPRESTI‐MORROW, et al. · Annals of the New York Academy of Sciences · 15

Inhibitors of MMP-1: an examination of P1′ Cα gem-disubstitution in the succinamide hydroxamate series

1996 · Ralph P. Robinson, John A. Ragan, et al. · Bioorganic & Medicinal Chemistry Letters · 9

Inhibitors of MMP-1: an examination of P1′ Cα gem-disubstitution in the N-carboxyalkylamine and glutaramide carboxylate series

1996 · Ralph P. Robinson, Brian J. Cronin, et al. · Bioorganic & Medicinal Chemistry Letters · 8

3‐Hydroxy‐4‐arylsulfonyltetrahydropyranyl‐3‐hydroxamic Acids Are Novel Inhibitors of MMP‐13 and Aggrecanase.

2004 · Mark C. Noe, Sheri L. Snow, et al. · ChemInform · 1

ChemInform Abstract: Design and Synthesis of 2‐Oxo‐imidazolidine‐4‐carboxylic Acid Hydroxyamides as Potent Matrix Metalloproteinase‐13 Inhibitors.

2001 · Ralph P. Robinson, Ellen R. Laird, et al. · ChemInform

ChemInform Abstract: Inhibitors of MMP‐1: An Examination of P′ 1 Cα gem‐ Disubstitution in the N‐Carboxyalkylamine and Glutaramide Carboxylate Series.

1996 · R. P. ROBINSON, B. J. CRONIN, et al. · ChemInform

ChemInform Abstract: Inhibitors of MMP‐1: An Examination of P′ 1 Cα gem‐ Disubstitution in the Succinamide Hydroxamate Series

1996 · R. P. ROBINSON, J. A. RAGAN, et al. · ChemInform

Works count: 15

Citation count: 344

H-index: 9

I10-index: 9